AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
VHI

Valhi Inc. Common Stock (VHI) fair value

Basic Materials · Chemicals · NYSE · United States
$14.32-0.07%
Market cap $406MNext earnings 2026-11-05Updated Oct 19, 2026
Add earnings to calendarGoogle
Our verdict
Trades 80% below our fair value
Price
$14.32
Model fair valueConfidence: low
about $70.77
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a loss-making company: Sales comps and Analyst consensus.
ACCE opinionValhi Inc. Common Stock (VHI)
Fair value (2 models)
Not available
ACCE price target
$14.00
Rating
Not rated
Horizon
12 months
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Price used: $14.32 at the close on 23 Oct 2026, 22:00 CEST.
Models: Analyst consensus and Sales comps.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
48
out of 100
Analysts
0% buy
1 covering
P/E
0.0x
forward 78.1x
1-year return
-0.7%
Dividend yield
2.29%

Valhi Inc. Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Valhi is a small chemicals holding company whose main operating asset is Kronos Worldwide, a producer of titanium dioxide pigment used in paints, plastics and paper, alongside component products and real estate. Its case rests on a mid-cycle recovery in TiO2 pricing and volumes, which would lift a business currently earning a thin 6.7% operating margin on a 14.9% gross margin. Revenue grew 12.2%, but the company is still loss-making at the return-on-equity line (-3.0%), and the 78.1x forward multiple shows the market is pricing in a substantial earnings rebound that has not yet appeared. With a $416M market cap and no index membership, it is under-followed, which can make it cheap on the right cycle turn and punishing on the wrong one. Worth a deeper look only if you have a view on TiO2 pricing and the holding-company discount.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • high
    Negative free cash flow
    FCF of -$82.1M against a $402M market cap is a large cash burn. Net margin is -2.4% and ROE is -3.0%, so the business is not yet covering its outflows from earnings.
  • moderate
    Thin float, heavy insider control
    Insiders hold 91.5% and institutions 4.2%, leaving a small tradable float. Price moves could be sharper than the company's fundamentals alone would imply.
  • moderate
    Sequential revenue drop
    Revenue fell 12.7% quarter over quarter even though it grew 12.2% year over year. The most recent quarter is weaker than the trend suggests.

AI research notes

AI-assisted·How I use AIWritten Oct 13, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Revenue grew 12.2% year over year in the latest 10-Q, well ahead of its 2.3% average annual pace over five years.
  • Debt is modest at 0.60 times equity, and the share count did not rise over the last fiscal year.
  • The stock still pays a 2.1% dividend yield, which gives income holders something while the business works through its losses.
Why it could disappoint
  • Free cash flow over the last twelve months was negative at -$82M, so the business is consuming cash rather than generating it.
  • Analysts' mean price target of $12.00 sits 16.1% below the $14.30 share price, and none rate the stock Buy or Strong Buy.
  • Earnings missed expectations by 18.7%, with EPS of 0.78 against 0.96 expected, and the net margin remains negative at -2.4%.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 5, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where VHI's valuation models land
Price
$14.32
Model fair valueConfidence: low
about $70.77
Model
Fair value
Upside
Analyst consensus
Sales comps
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bearish0% buy · 1 covering analyst
● Strong buy 0● Buy 0● Hold 0● Sell 1● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-2.5%
1 month
-12.3%
3 months
+5.1%
6 months
-1.2%
YTD
+18.8%
1 year
-0.7%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
15 Oct 2026, 00:00 CESTACCE price target$14.00first publication$14.36
6 Oct 2026, 00:00 CESTFair value$17.78$17.60$14.89
30 Sept 2026, 00:00 CESTFair value$17.60$18.39$15.51
27 Sept 2026, 00:00 CESTFair value$18.39$18.78$15.99
23 Sept 2026, 00:00 CESTFair value$18.78$18.55$16.82
20 Sept 2026, 00:00 CESTFair value$18.55$17.64$16.56
18 Sept 2026, 00:00 CESTFair value$17.64$19.01$16.48
16 Sept 2026, 00:00 CESTFair value$19.01$19.69$18.10
9 Sept 2026, 00:00 CESTFair value$19.69$19.44$17.83
3 Sept 2026, 00:00 CESTFair value$19.44$19.84$18.08

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full VHI page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth76Value36Quality32Momentum47Total48
Valuation
Trailing P/E
0.0x
Forward P/E
78.1x
PEG
no data
P/B
0.44x
EV / Revenue
0.4x
Book value/sh
$36.87
Enterprise value
$857M
Profitability
ROE
-3.0%
FCF yield
-20.23%
ROIC
-2.9%
Health and risk
Debt / equity
0.60
Dividend yield
2.29%
Beta
1.06

Price

-2.5% · 1Y

Ask anything about VHI

Answered from Valhi Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
ROEbetter than 67% of peers
low -549%-3%high 7%
Div yieldbetter than 67% of peers
low 0.0%2.3%high 5.8%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
VHI Valhi Inc. Common Stock$14.32----3.0%3248
ASIX AdvanSix Inc. Common Stock $15.71$3453% below--2.2%2726
BAK Braskem SA ADR$1.70----548.8%2649
RYAM Rayonier Advanced Materials Inc. Common Stock$6.70----49.7%1735
TROX Tronox Holdings plc Ordinary Shares (UK)$3.46----41.3%1742
SGL.DE SGL Carbon SE€4.89€344% above--7.1%4045
LXU LSB Industries Inc. Common Stock$9.89$826% above19.5x7.1%3845

Sector report card

Where VHI ranks against its sector peers on each metric.

Computing percentiles…
  • GlobeNewswire•Aug 6, 2026
    VALHI DECLARES QUARTERLY DIVIDEND
  • GlobeNewswire•Aug 6, 2026
    VALHI REPORTS SECOND QUARTER 2026 RESULTS
  • GlobeNewswire•Aug 6, 2026
    VALHI REPORTS SECOND QUARTER 2026 RESULTS
10 more press releases · full archive on Investor+.INVESTOR
19 filings of 40
August 2026
Aug 6
8-KCurrent reportPeriod 2026-08-06
View on SEC →
Aug 6
10-QQuarterly reportPeriod 2026-06-30
View on SEC →
June 2026
Jun 22
8-KCurrent reportPeriod 2026-06-17
View on SEC →
16 more filings + AI summaries on Investor+.INVESTOR